Israel Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Published by: Global Markets Direct

Published: Sep. 28, 2009 - 60 Pages

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

3 Definitions of the Markets Covered in the Report

3.1 Drug Delivery Devices

3.2 Inhalation Systems

3.2.1 Metered Dose Inhaler

3.2.2 Dry Powder Inhaler

3.3 Infusion Systems

3.3.1 Infusion Pumps

3.3.2 Syringe Pumps

3.3.3 Disposable Infusion Sets

4 Healthcare Sector Review

4.1 Healthcare Sector Review

4.2 Healthcare Expenditure

5 Regulation System

5.1 Regulatory System

5.2 Registration

5.3 Standards

5.4 Customs Duties

5.5 Labeling

6 Pricing and Reimbursement

7 Distribution Structure

8 Drug Delivery Devices In Israel

8.1 Drug Delivery Devices, Israel, Overall Revenue ($ mn), 2000-2015

8.2 Drug Delivery Devices, Israel, Category Volume (Units), 2000-2015

8.3 Drug Delivery Devices, Israel, Company Share (2007-2008)

9 Infusion Systems In Israel

9.1 Infusion Systems Overall Revenue (2000-2015)

9.2 Infusion Systems Overall Volume (2000-2015)

9.3 Infusion Systems Average Price (2000-2015)

9.4 Infusion Systems Distribution Share (2007-2008)

9.5 Infusion Systems, Israel, Company Share (2007-2008)

10 Inhalation Systems In Israel

10.1 Inhalation Systems Overall Revenue (2000-2015)

10.2 Inhalation Systems Overall Volume (2000-2015)

10.3 Inhalation Systems Average Price (2000-2015)

10.4 Inhalation Systems Distribution Share (2007-2008)

10.5 Inhalation Systems, Israel, Company Share (2007-2008)

11 Overview of Key Companies in Israel Drug Delivery Devices Market

11.1 Terumo Corporation

11.1.1 Company Overview

11.2 Smiths Medical

11.2.1 Company Overview

11.3 Novartis AG

11.3.1 Company Overview

11.4 Hospira, Inc.

11.4.1 Company Overview

11.5 GlaxoSmithKline plc

11.5.1 Company Overview

11.6 Fresenius Kabi AG

11.6.1 Company Overview

11.7 Cardinal Health, Inc.

11.7.1 Company Overview

11.8 Boehringer Ingelheim GmbH

11.8.1 Company Overview

11.9 Consort Medical plc

11.9.1 Company Overview

11.9.2 Bespak plc Pipeline Products

11.9.2.1 Bespak plc Pipeline Products By Equipment Type

11.9.2.2 Bespak plc Pipeline Products By Development Stage

11.9.2.3 Bespak plc Pipeline Products By Therapy Area

11.10 Baxter International Inc.

11.10.1 Company Overview

11.11 B. Braun Melsungen AG

11.11.1 Company Overview

11.12 AstraZeneca PLC

11.12.1 Company Overview

11.13 SpiroJet Medical Ltd.

11.13.1 Company Overview

11.14 E-Pill Pharma Ltd.

11.14.1 Company Overview

11.15 Elcam Medical

11.15.1 Company Overview

11.16 Meytav Technological Incubator

11.16.1 Company Overview

11.17 SteadyMed Ltd.

11.17.1 Company Overview

11.17.2 SteadyMed Ltd. Pipeline Products

11.17.2.1 SteadyMed Ltd. Pipeline Products By Equipment Type

11.17.2.2 SteadyMed Ltd. Pipeline Products By Development Stage

11.17.2.3 SteadyMed Ltd. Pipeline Products By Therapy Area

11.17.2.4 SteadyMed Ltd. Pipeline Products By News Summary

11.18 Maya Biotech Ltd.

11.18.1 Company Overview

11.18.2 Maya Biotech Ltd. Pipeline Products

11.18.2.1 Maya Biotech Ltd. Pipeline Products By Equipment Type

11.18.2.2 Maya Biotech Ltd. Pipeline Products By Development Stage

11.18.2.3 Maya Biotech Ltd. Pipeline Products By Therapy Area

11.19 RescueDose L.T.D.

11.19.1 Company Overview

11.19.2 RescueDose L.T.D. Pipeline Products

11.19.2.1 RescueDose L.T.D. Pipeline Products By Equipment Type

11.19.2.2 RescueDose L.T.D. Pipeline Products By Development Stage

11.19.2.3 RescueDose L.T.D. Pipeline Products By Therapy Area

11.20 Medihale Ltd.

11.20.1 Company Overview

11.20.2 Medihale Ltd. Pipeline Products

11.20.2.1 Medihale Ltd. Pipeline Products By Equipment Type

11.20.2.2 Medihale Ltd. Pipeline Products By Development Stage

11.20.2.3 Medihale Ltd. Pipeline Products By Therapy Area

12 Appendix

12.1 Global Markets Direct Research Methodology

12.2 Secondary Research

12.3 Primary Research

12.4 Models

12.5 Forecasts

12.6 Expert Panel Validation

12.7 Currency Conversion

12.8 Contact Us

12.9 Disclaimer

1.1 List of Tables

Table 1: Total Healthcare Expenditure, Israel, 2000 - 2007

Table 2: Drug Delivery Devices, Israel, Overall Revenue ($ mn), 2000-2015

Table 3: Drug Delivery Devices, Israel, Cross-Category Analysis, 2000-2015

Table 4: Drug Delivery Devices, Israel, Overall Revenue ($ mn), Historic, 2000-2008

Table 5: Drug Delivery Devices, Israel, Overall Revenue ($ mn), Forecast, 2008-2015

Table 6: Drug Delivery Devices, Israel, Category Volume (Units), 2000-2015

Table 7: Drug Delivery Devices, Israel, Category Volume (Units), Historic, 2000-2008

Table 8: Drug Delivery Devices, Israel, Category Volume (Units), Forecast, 2008-2015

Table 9: Drug Delivery Devices, Israel, Company Share by Revenue ($ mn), 2007-2008

Table 10: Infusion Systems, Israel, Revenue ($ mn) by Segment, Historic, 2000-2008

Table 11: Infusion Systems, Israel, Revenue ($ mn) by Segment, Forecast, 2008-2015

Table 12: Infusion Systems, Israel, Volume (Units) by Segment, Historic, 2000-2008

Table 13: Infusion Systems, Israel, Volume (Units) by Segment, Forecast, 2008-2015

Table 14: Infusion Systems, Israel, Average Price ($), Historic, 2000-2008

Table 15: Infusion Systems, Israel, Average Price ($), Forecast, 2008-2015

Table 16: Infusion Systems, Israel, Distribution Share by Revenue ($mn), 2007-2008

Table 17: Infusion Systems, Israel, Company Share by Revenue ($ mn), 2007-2008

Table 18: Inhalation Systems, Israel, Revenue ($ mn) by Segment, Historic, 2000-2008

Table 19: Inhalation Systems, Israel, Revenue ($ mn) by Segment, Forecast, 2008-2015

Table 20: Inhalation Systems, Israel, Volume (Units) by Segment, Historic, 2000-2008

Table 21: Inhalation Systems, Israel, Volume (Units) by Segment, Forecast, 2008-2015

Table 22: Inhalation Systems, Israel, Average Price ($), Historic, 2000-2008

Table 23: Inhalation Systems, Israel, Average Price ($), Forecast, 2008-2015

Table 24: Inhalation Systems, Israel, Distribution Share by Revenue ($mn), 2007-2008

Table 25: Inhalation Systems, Israel, Company Share by Revenue ($ mn), 2007-2008

Table 26: Bespak plc Pipeline Products by Equipment Type

Table 27: Bespak plc Pipeline Products By Development Stage

Table 28: Bespak plc Pipeline Products By Therapy Area

Table 29: SteadyMed Ltd. Pipeline Products by Equipment Type

Table 30: SteadyMed Ltd. Pipeline Products By Development Stage

Table 31: SteadyMed Ltd. Pipeline Products By Therapy Area

Table 32: SteadyMed Ltd. Pipeline Products By News Summary

Table 33: Maya Biotech Ltd. Pipeline Products by Equipment Type

Table 34: Maya Biotech Ltd. Pipeline Products By Development Stage

Table 35: Maya Biotech Ltd. Pipeline Products By Therapy Area

Table 36: RescueDose L.T.D. Pipeline Products by Equipment Type

Table 37: RescueDose L.T.D. Pipeline Products By Development Stage

Table 38: RescueDose L.T.D. Pipeline Products By Therapy Area

Table 39: Medihale Ltd. Pipeline Products by Equipment Type

Table 40: Medihale Ltd. Pipeline Products By Development Stage

Table 41: Medihale Ltd. Pipeline Products By Therapy Area

Table 42: USD to Local Currency, Average Exchange Rate 2008

1.2 List of Figures

Figure 1: Total Healthcare Expenditure, Israel, 2000 - 2007

Figure 2: Government and Private Healthcare Expenditure in Israel, 2007

Figure 3 Drug Delivery Devices, Israel, Overall Revenue ($ mn), 2000-2015

Figure 4: Drug Delivery Devices, Israel, Cross-Category Analysis, 2000-2015

Figure 5 Drug Delivery Devices, Israel, Overall Revenue ($ mn), Historic, 2000-2008

Figure 6 Drug Delivery Devices, Israel, Overall Revenue ($ mn), Forecast, 2008-2015

Figure 7 Drug Delivery Devices, Israel, Category Volume (Units), 2000-2015

Figure 8 Drug Delivery Devices, Israel, Category Volume (Units), Historic, 2000-2008

Figure 9 Drug Delivery Devices, Israel, Category Volume (Units), Forecast, 2008-2015

Figure 10 Drug Delivery Devices, Israel, Company Share (%), 2008

Figure 11 Infusion Systems, Israel, Revenue ($ mn) by Segment, Historic, 2000-2008

Figure 12 Infusion Systems, Israel, Revenue ($ mn) by Segment, Forecast, 2008-2015

Figure 13 Infusion Systems, Israel, Company Share (%), 2008

Figure 14 Inhalation Systems, Israel, Revenue ($ mn) by Segment, Historic, 2000-2008

Figure 15 Inhalation Systems, Israel, Revenue ($ mn) by Segment, Forecast, 2008-2015

Figure 16 Inhalation Systems, Israel, Volume (Units) by Segment, Historic, 2000-2008

Figure 17 Inhalation Systems, Israel, Volume (Units) by Segment, Forecast, 2008-2015

Figure 18 Inhalation Systems, Israel, Company Share (%), 2008

Figure 19 Global Markets Direct Methodology

Abstract

Israel Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to Israel drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the drug delivery devices market in Israel

Scope

• The report provides information on the drug delivery devices market in Israel.
• Details on the key segments and categories such as Inhalation Systems, Needle Free Injections, and Infusion Systems.
• Total revenues, products sold, end users, and average pricing.
• Market shares of all the key competitors such as GlaxoSmithKline plc, AstraZeneca International plc, Boehringer Ingelheim GmbH, Novartis AG, and Fresenius Kabi AG.
• Key pipeline products that are set to shape the market, broken down by sector.
• Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
• Key mergers and acquisitions, partnerships, private equity investments and IPOs.
• Customer, hospitals and physicians data.

Reasons to buy

• Gain a strong understanding of the drug delivery devices market in Israel.
• Evaluate and compare the attractiveness of the market in the country.
• Identify growth segments and opportunities in each industry sector within the country.
• Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
• Analyze the competitiveness of the market in the country and identify hotspots.
• Develop strategies based on the latest product, brand, expansion and research and development news in the country.
• Plan deal strategies with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
• Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Get Full Details About This Report >>

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.